Monocyte Chemotactic Protein-1 (MCP1) Accumulation in Human Osteoclast Precursor Cultures

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Osteoclast formation in vitro typically requires macrophage colony stimulating factor (M-CSF) and receptor activator of NF-κB ligand (RANKL).
• Granulocyte macrophage colony stimulating factor (GM-CSF) inhibits human osteoclastogenesis in vitro.
• Monocyte chemotactic protein-1 (MCP1) can enhance osteoclast formation and counteract GM-CSF-induced suppression.

Purpose of the Study:

• To investigate the impact of M-CSF and GM-CSF on chemokine expression in human CD14+ cells.
• To elucidate the role of MCP1 and its receptor CCR2 in osteoclast formation.
• To understand how GM-CSF influences MCP1 production and subsequent osteoclastogenesis.

Main Methods:

• Culturing human CD14+ cells with M-CSF, GM-CSF, or both.
• Assaying mRNA and protein levels of various chemokines, focusing on MCP1.
• Utilizing a C-C chemokine receptor-2 (CCR2) antagonist (RS102895) to assess its effect on osteoclast formation and RANK expression.

Main Results:

• MCP1 was the most abundant chemokine in M-CSF treated cultures, with protein levels reaching up to 50 ng/mL.
• GM-CSF suppressed MCP1 expression in these cultures.
• Inhibition of CCR2 by RS102895 reduced osteoclast-like cell formation, partly by decreasing RANK expression.

Conclusions:

• MCP1 is a key mediator in M-CSF driven osteoclast formation and can overcome GM-CSF mediated suppression.
• GM-CSF negatively regulates MCP1 production, impacting osteoclastogenesis.
• Targeting the MCP1-CCR2 axis, potentially via CCR2 antagonists, could modulate osteoclast formation and RANK expression.